Physician profile
Randall Bumsted
NPI 1598745689
$4,309.04
in general payments reported to CMS, 2019-2025
12 companies · $631 in 2025
The $631 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,888 · 2020: $11.12 · 2021: $1,257 · 2022: $305 · 2023: $117 · 2024: $99.45 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.62 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $203.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,656.29 | 2019-2021 | |
| Alcon Vision LLC | $1,132.11 | 2021 | |
| Coopervision INC. | $497.87 | 2022-2025 | Misight Contact Lens, Clariti Contact Lens |
| Dompe US, INC. | $157.91 | 2025 | Oxervate |
| Visionix USA, INC | $140.00 | 2022 | |
| Allergan, INC. | $125.00 | 2019 | |
| Abbvie INC. | $124.04 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $122.60 | 2019 | |
| Bausch & Lomb Americas INC. | $117.46 | 2023 | Revive |
| Lkc Technologies, INC. | $115.65 | 2025 | |
| Optovue, INC. | $108.99 | 2019 | |
| Optos, INC. | $11.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Bumsted listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.